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Abstract
It has been recently recognized that mammalian mitochondria contain most, if not all, of the components of fatty acid
synthesis type II (FAS II). Among the components identified is 2-enoyl thioester reductase/mitochondrial enoyl-CoA
reductase (Etr1/Mecr), which catalyzes the NADPH-dependent reduction of trans-2-enoyl thioesters, generating saturated
acyl-groups. Although the FAS type II pathway is highly conserved, its physiological role in fatty acid synthesis, which
apparently occurs simultaneously with breakdown of fatty acids in the same subcellular compartment in mammals, has
remained an enigma. To study the in vivo function of the mitochondrial FAS in mammals, with special reference to Mecr,w e
generated mice overexpressing Mecr under control of the mouse metallothionein-1 promoter. These Mecr transgenic mice
developed cardiac abnormalities as demonstrated by echocardiography in vivo, heart perfusion ex vivo, and electron
microscopy in situ. Moreover, the Mecr transgenic mice showed decreased performance in endurance exercise testing. Our
results showed a ventricular dilatation behind impaired heart function upon Mecr overexpression, concurrent with
appearance of dysmorphic mitochondria. Furthermore, the data suggested that inappropriate expression of genes of FAS II
can result in the development of hereditary cardiomyopathy.
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Introduction
Progress in molecular cardiology has revealed circumstances
predisposing individuals to development of cardiomyopathies.
Many of the genetic factors identified involve receptors in the
myocardial sarcolemma, ion channels, and the cytoskeleton or
contractive machinery. Energy metabolism restrictions, arising
from mitochondriopathies or other inborn errors, frequently show
a cardiac phenotype.
In mammalian cells, a vast majority of endogenously derived
fatty acids are synthesized in the cytosol through a large
polyfunctional enzyme in which each of the reactions is catalyzed
by distinct domains (FAS I) [1]. Other processes which can
contribute to cellular fatty acid synthesis are fatty acid chain
elongation in the endoplasmic reticulum [2], and the recently
identified mitochondrial fatty acid synthesis (FAS II) [3–8]. In this
system, the required activities are catalyzed by separate enzymes
and, therefore, the system resembles the well-characterized
bacterial machinery [9].
Acyl carrier protein (ACP) of FAS II from mammalian
mitochondria was isolated first as a component of complex I of
the respiratory chain [10], but a soluble ACP pool has also been
described [7]. Most of other FAS II components in mammals,
including human, were originally identified in silico on the basis of
amino acid sequence similarities with proteins characterized from
other organisms such as prokaryotes, fungi or plants [3–5,11].
Among the components which have been alighted on the basis of
similarities to fungal proteins is 2-enoyl thioester reductase, which
is also known as nuclear receptor binding factor 1, Nrbf1, or as
mitochondrial enoyl-CoA reductase (Etr1/Mecr; EC 1.3.1.38).
This enzyme catalyzes the reaction:
trans-2-enoyl- ACP=CoA ðÞ zNADPHzHz
?acyl- ACP=CoA ðÞ zNADPz,
the last step of fatty acid synthesis spiral [4,12]. The murine
protein is encoded by Mecr, at CCDS18715 on chromosome 4,
and the corresponding human gene MECR is located at
CCDS30659 on chromosome 1.
To shed light on the function of the human mitochondrial FAS
II, we used mice as a model system and report here generation of
an artificial imbalance in the expression of Mecr when it is put
under the control of the mouse metallothionein-1 (MT-1)
promoter. The Mecr transgenic mice manifested focal mitochon-
drial clumping in myocardium, decreased cardiac mechanical
PLoS ONE | www.plosone.org 1 May 2009 | Volume 4 | Issue 5 | e5589function and decreased performance in the endurance tolerance
test. Moreover, this work paves the road for identification of a
novel set of genes whose improper expression could trigger
development of cardiomyopathies.
Results
On-going research has revealed a number of mitochondrial
processes whose existence has been recognized just recently. For
instance, data coming from several laboratories indicate that
mitochondria are capable of catalyzing de novo fatty acid synthesis
[3–8]. Although experimental evidence shows that this conserved
pathway is essential for mitochondrial respiratory function in fungi
[12–14], its role in mammals has remained open. Here we
describe the generation and analysis of mice overexpressing Mecr
under the control of MT-1 promoter (Figure 1B). (i) Mecr was
chosen because its gene product, Etr1/Mecr, is among the FAS II
components which have been characterized best in mammals [4].
(ii) Mitochondrial respiratory function is highly dependent on its
expression in the yeast model system [12], and (iii) MT-1 promoter
is ubiquitously active in mice allowing sampling of multiple tissues
for screening of responses in transgenic animals [15–17].
Generation of Mecr transgenic mice
Two transgenic founders (tg60 and tg62) were generated which
transmitted the transgene to their offspring in a Mendelian
fashion. The different fragment sizes, visualized by Southern
blotting, indicated that the transgenic construct was integrated into
different locations of the genome in the tg60 and tg62 lines without
any hint of multiple integrations (Figure 1C). When tissues from
the Mecr transgenic mice lines were analyzed using histological
approaches either by light or electron microscopies with
morphological criteria, the affected organ was heart (Figure 2).
In line with this, both lines of the Mecr transgenic mice displayed
dysfunctional cardiac phenotype (see below). The Mecr in wild-type
mice is expressed actively in kidney and liver, and moderately in
heart and other tissues as shown by Northern blot and in silico
analysis using data from UniGene database of the National Center
for Biotechnology Information (NCBI) (Figure 1A).
Reverse template PCR showed that mRNA levels of Mecr was
higher than wild type in heart muscle of both Mecr transgenic lines
(Figure 1D). The increase was confirmed by semiquantitative real
time PCR, the mRNA levels being 1.0560.09 in wild type animals
(wt) and 1.7260.26 (P,0.01, vs. wt) and 13.362.8 (P,0.005, vs.
wt) in tg60 and tg62, respectively (Figure 1E). When assayed, livers
and muscle tissues from Mecr transgenic mice did not show
significant increase of Mecr in mRNA levels. To test whether the
overexpression construct was properly transcribed and processed,
cDNA for artificial Mecr was prepared from tg62, the nucleotide
sequence was checked, the cDNA was subcloned into the pET3a
vector and expressed in BL21(DE3) pLysS cells. The soluble
protein supernatant of the cell lysate was subjected to ADP-
Sepharose chromatography, and the fractions showing Etr1/Mecr
activity were analyzed by SDS-PAGE and mass spectrometry. A
positive band from the active fractions was confirmed by mass
spectrometry to be Etr1/Mecr. To confirm this further, the
artificial cDNA was cloned into pET23a vector containing a C-
terminal His6-tag and the tagged Etr1/Mecr variant was purified
to homogeneity using Ni-NTA and size exclusion chromatography
columns (Figure 1F). The purified tagged Etr1/Mecr was
enzymatically active when tested with C4 - C16 2-enoyl-CoA
substrates. These results demonstrated that the Etr1/Mecr
transgene mRNA is properly processed and encodes enzymatically
active protein.
However, the demonstration of increased Etr1/Mecr in Mecr
transgenic hearts failed based on both immunoblot analysis and
enzyme activity assays, for discussion, see below. Administration of
zinc either by adding 25 mmol/L ZnSO4 to drinking water (tested
for 1 week and 1 month) or by i.p. injection with ZnSO4?7H2O
(20 mg/kg, animals were sacrificed 24 h after injection as
described in references [18,19], gave no further increase in Etr1/
Mecr mRNA in either of the Mecr transgenic line. Therefore, this
study was continued without administration of zinc to animals.
The weight gain and litter sizes of Mecr transgenic mice did not
differ significantly from wild type controls. The life span of the
transgenic mice was not different from that of wild type
littermates. The expression level of various heart failure mark
genes [20], e.g., myosin heavy chain (aMHC), sarcoplasmic or
endoplasmic reticulum calcium adenosine triphosphatase 2
(SERCA2), atrial natriuretic peptide (ANP), brain natriuretic
peptide (BNP), and relevant transcription factors, e.g., nuclear
respiratory factor-1 (NRF1) [21], peroxisome proliferator-activat-
ed receptor c coactivator 1-a (PGC-1a) [22], peroxisome
proliferator-activated receptor (PPARa) [22], estrogen-related
receptor a (ERRa) [21], were monitored using semiquantitative
real time PCR. The mRNA levels of ANP, BNP, ERRa, aMHC,
NRF1, PGC-1a, PPARa, and SERCA2 were 1.2960.25,
1.0060.23, 1.1560.45, 0.8560.43, 1.0960.36, 0.9160.22,
0.9460.22, and 0.9760.21, respectively (n=5, n.s.), when the
mRNA levels in the wild type animals were set to 1.0.
Morphology of heart and mitochondria
In haematoxylin-eosin staining, transgenic hearts, when com-
pared to wild type, showed slightly distorted myofibers (Figure 2A,
a1 and a2). However, the heart weight/body weight of transgenic
mice did not differ significantly from that of wild type controls
(Figure 2A, a3). In toluidine blue sections taken from plastic
embedded material, cardiomyocytes in transgenic hearts displayed
a mosaic staining whereas the cells in wild type controls showed
even staining (Figure 2A, a4 and a5). The average diameter of
myocytes was 21.863.1 mm for wild type and 31.164.5 mm for
tg62 (P,0.001). TUNEL staining showed an increased number of
positive nuclei in transgenic hearts (52624 for wild type vs.
106638 for tg62 per 10 high-power fields; P,0.005) (Figure 2A,
a7 through a9).
Transmission electron microscopy showed focal disorganiza-
tions of myofibrils and aberrant mitochondria in transgenic hearts
(Figure 2B, b1 and b2). Furthermore, the mitochondria in
transgenic hearts appeared to be densely packed, so that even
parts of the outer membranes were sometimes fused; also,
degenerating swollen mitochondria were often detected
(Figure 2B, b3). Especially in large mitochondria, the cristae
density was high when compared to wild type organelles
(Figure 2B, b4 and b5). The average diameter of mitochondria
was enlarged in transgenic hearts (0.5160.05 mm for wild type
and 0.6860.06 mm for tg62, P,0.001) (Figure 2B, b6). Mice from
both tg60 and tg62 lines showed similar phenotype in histological
analysis.
Cardiac function in vivo
Cardiac function was evaluated using echocardiography in vivo.
Both female and male Mecr transgenic mice showed similar
impaired cardiac phenotype compared to their wild type
littermates (data not shown). Female mice were chosen for further
studies. Both tg60 and tg62 transgenic lines had significantly
decreased cardiac systolic function (Figure 3A and 3B). In
particular, the ejection fraction was reduced in Mecr transgenic
mice (95.463.2% in wt vs. 88.163.3% in tg60 and 85.363.9% in
Mecr and Heart Impairment
PLoS ONE | www.plosone.org 2 May 2009 | Volume 4 | Issue 5 | e5589Figure 1. The generation of Mecr transgenic mice. A. Tissue expression pattern of Mecr in mice. The upper panel showed result of Northern
blot. The lower panel showed the in silico analysis of Mecr expression pattern estimated from EST sources (UniGene, NCBI). The number indicated in y-
axis refers to transcripts per million (TPM) that was calculated by the number of gene EST divided by totoal EST in pool of the indicated tissues. The
symbol h, b, k, li, lu, sp, m, and ad refer to heart, brain, kidney, liver, lung, spleen, muscle, and adipose tissue, respectively. B. Transgenic construct
consisting of the MT-1 promoter driving mouse Mecr expression; a 59 noncoding region of the human ODC gene which includes the first two introns;
full length mouse Etr1/Mecr cDNA including the translation initiation codon (ATG) and the stop codon in frame; followed by the 39 UTR and
termination signal of the mouse Mecr gene (Term. Mecr). C. Southern blot genotyping, schematic presentation of the integration of the Mecr
transgenic construct into the mouse genome. Mouse genomic DNA was digested by BamHI, giving a 6 kb fragment which is a marker for the
transgene construct. The arrow head showed the size of the transgene construct (,6 kb); the unfilled arrow shows an additional 9.5 kb fragment
recognized by the probe only in tg62. The greater intensity of the 6 kb transgene band over that of the single-copy wild type band seen at
approximately 4.3 kb in all three DNA samples demonstrates integration of multiple copies of the construct. The 9.5 kb signal arises from the 59 end
of the construct together with about 3.5 kb from the integration site. D. Reverse template PCR analysis of Mecr expression levels. Oligonucleotides
which can recognize Mecr mRNA were used in left picture. The solid arrow shows an 800 bp band that was detected both in wild type and Mecr
transgenic samples. Transgenic construct specific oligonucleotides were used in right picture. The unfilled arrow shows a 1.2 kb band detected only
in Mecr transgenic samples. E. Real time PCR analysis of Mecr expression levels. Results are expressed as mean6SD (n=4) **P,0.01 Mecr transgenic
mice vs. wild type control. F. SDS-PAGE analysis of the purified His6-tagged Etr1/Mecr protein. The visualized band at 37 kDa corresponds to the
predicted size of the peptide chain expressed from E. coli.
doi:10.1371/journal.pone.0005589.g001
Mecr and Heart Impairment
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5589tg62; P,0.01) (Figure 3A) and fractional shortening was reduced
as well (66.868.7% in wt vs. 52.264.6% in tg60 and 48.564.5%
in tg62; P,0.01) (Figure 3B). The thickness of the interventricular
septum did not significantly differ between groups showing that
there was no hypertrophy present in Mecr transgenic mice
(Figure 3C). In support of this, the thickness of the left ventricular
posterior wall was even decreased in tg62 (1.260.3 mm in wt vs.
0.860.1 mm in tg62; P,0.05) (Figure 3D). Noteworthily, in the
tg62 (high expression), but not in the tg60 (low expression)
transgenic line, left ventricular dilatation was seen, as the diameter
of the left ventricle was significantly greater than in wild type
(2.960.4 mm in wt vs. 3.160.4 mm in tg60, p=0.47 and
3.460.3 mm in tg62, P,0.05) (Figure 3E).
Left ventricular mass measured by echocardiography was
120611 mg in wild type mice and 164617 mg in Mecr transgenic
mice (n.s.). The decreased systolic function and left ventricular
Figure 2. Histological analysis. A. Haematoxylin-eosin staining showed slightly distorted and wavy myofibers in Mecr transgenic hearts (a1 and
a2). There is no significant difference in heart weight/body weight between wild type and Mecr transgenic mice (a3). Toluidine blue staining showed
an uneven staining pattern in transgenic cardiomyocytes (a4 and a5). The diameter of myofibers was greater in transgenic heart than in wild type (SD
(n=6) ***P,0.001) (a6). TUNEL staining showed an increased number of positively stained nuclei (SD (n=5) **P,0.005) in Mecr transgenic mice vs.
controls (a7 through a9). B. Transmission electron micrographs show well-organized myofibrils and regularly located mitochondria in wild type hearts
(b1), whereas in Mecr transgenic hearts myofibrils are disorganized (b2). Accumulated mitochondria and a few degenerating organelles can be also
seen (b3). High-density cristae were only observed in transgenic mitochondria (b4). b5 shows an enlargement of the indicated area in b4. The average
diameter of mitochondria is larger in Mecr transgenic mice than in wild type controls (SD (n=6) ***P,0.001) (b6). Bars represent 1 mm (b1–b3) and
200 nm (b4), respectively. ‘‘m’’ represents mitochondrion. The arrows show distorted myofibrils; the arrow heads point to degenerated
mitochondrion.
doi:10.1371/journal.pone.0005589.g002
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importance of Mecr in dilatative rather than hypertrophic processes
in the heart.
Mechanical function of isolated perfused heart
The hearts from MECR transgenic mice and wild type controls
were subjected to retrograde perfusion according to the Langen-
dorff procedure [23]. Values from the two MECR transgenic
groups did not differ significantly and were therefore pooled. The
mechanical work output of the hearts was monitored at three
workload levels: at their endogenous beating frequency (3.2–
3.8 Hz), pacing at 5 Hz, and pacing at 7.5 Hz. Work output was
given as the product of dPmax/dt and heart rate in arbitrary units.
At the endogenous frequency, the average work output for the 23–
24 min perfusion interval was not significantly different in MECR
transgenic hearts (36.2611.6) from that of wild-type controls
(38.365.9), although the heart rate tended to be slower in the
transgenic hearts (2.95 Hz60.70, mean6SD) than in controls
(3.4360.69, mean6SD) (Figure 4A). At the paced beating
frequency of 5 Hz (27–29 min), average work output was also
Figure 3. Echocardiography of wild type, Mecr transgenic line tg60, and Mecr transgenic line tg62. A. Ejection fraction; B. Fractional
shortening; C. Interventricular septum in diastole; D. Left ventricular posterior wall in diastole; E. Diameter of left ventricle in diastole. Results are
expressed as mean6SD (wt n=9; tg60 n=4; tg62 n=5). *P,0.05, **P,0.01, Mecr transgenic mice vs. wild type controls.
doi:10.1371/journal.pone.0005589.g003
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PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5589Figure 4. Changes in work output, redox state of mitochondrial respiratory chain, oxygen consumption, and heart rate of isolated
perfused hearts from wild type and Mecr transgenic mice. From the 25 min time point, the hearts were electrically paced to 5 Hz and from the
30 min time point they were paced to 7.5 Hz. A. The heart-rate-related work output changes are significant in the wild type hearts (P=0.011),
whereas they are not in the Mecr transgenic hearts (P=0.737). B. Redox changes of cytochrome oxidase as measured by reflectance spectrum
changes. A reflectance decrease indicates a shift of the redox state towards reduction. The heart rate-related change in the redox state of cytochrome
oxidase is significant in both groups (P,0.001). C. Flavoprotein redox state as measured by means of flavin fluorescence. An increase in fluorescence
indicates oxidation. D. Oxygen consumption. The curves represent means6SD from 5 and 8 independent experiments on Mecr transgenic and
control hearts, respectively.
doi:10.1371/journal.pone.0005589.g004
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controls (65.6611.8) (Figure 4A). At 7.5 Hz (32–34 min), the work
output was 58.0625.1 in the MECR transgenic hearts and
81.9610.2 in controls (Figure 4A). In the wild type hearts there
was a linear correlation (P,0.005) between heart rate and work
output, whereas the MECR transgenic hearts did not increase their
work output in proportion to pacing frequency. When the pacing
was increased to 10 Hz, the wild type hearts responded, but the
MECR transgenic hearts did not (data not shown).
Cellular redox state and oxygen consumption
The mitochondrial redox state was monitored at two levels of
the respiratory chain, the cytochrome c oxidase and the free
NADH/NAD
+ pool. The redox state of cytochrome c oxidase, the
terminal oxidase of the mitochondrial respiratory chain, was
monitored by reflectance spectrum changes. A shift towards
reduction was seen upon increase in the workload, in agreement
with the current view of regulation of mitochondrial respiration
(Figure 4B), and the effect of the pacing frequency change was
smaller in the MECR transgenic hearts than in wild type.
The mitochondrial matrix NADH/NAD
+ ratio can be
monitored in a compartment-specific manner by recording
flavoprotein fluorescence signal, which is mainly contributed by
the lipoamide dehydrogenase of the mitochondrial oxoacid
dehydrogenases and is in equilibrium with the NADH/NAD
+
pool [24]. It was found that an increase in workload caused an
increase in flavin fluorescence, indicating decrease in the NADH/
NAD ratio (Figure 4C), and the effect of workload increase was
smaller in the MECR transgenic hearts.
Oxygen consumption increased upon increase in the workload
in all experimental groups. The MECR transgenic hearts differed
from the controls in that the increase upon heart rate increase
from 5 to 7.5 Hz was smaller, although this is in accord with the
smaller increase in work output due to an increase in the pacing
frequency from 5 to 7.5 Hz (Figure 4D).
The CrP/Pi ratio in the MECR transgenic hearts (1.2660.17)
(mean6SD) after pacing at 7.5 Hz tended to be lower than that in
controls (1.4060.43). Experimental variation was large so the
difference did not reach statistical significance. The CrP/Pi ratio is
a parameter well suited to describing the cellular energy state in
tissues containing creatine kinase, since the changes in the CrP and
Pi concentrations are usually reciprocal.
The mitochondria were isolated from mouse livers and hearts,
and the rates of the state 3 and 4 respiration were monitored in the
presence of various substrates. There were no significant
differences in the respiratory rates between the mitochondria
from wild-type and transgenic mice livers and hearts (Table S1).
The results suggest that the decreased physiological performance
as detected ex vivo (Figure 4) might not result from general
impairment of mitochondrial function, but rather from uneven
distribution of dysfunctional mitochondria in myocardial cells in
Mecr transgenic mice. This suggestion is also in line with
observations visualized by electron microscopy (Figure 2B).
Exercise endurance test
Exercise intolerance is one of the key symptoms of dilated
cardiomyopathy. Because Mecr transgenic mice expressed a
phenotype with some features of dilated cardiomyopathies, we
challenged the mice to exercise on a treadmill. Three parameters
were monitored: running distance, vertical distance and vertical
work performance. Treadmill values for wild type mice (value for
tg62 in parenthesis) for running distance were 7406150 m
(396685 m, P,0.005), for vertical distance were 301681 m
(118643 m, P,0.005) and for vertical work performance were
8.4561.85 kg m (3.6261.62 kg m, P,0.005) (Figure 5A through
5C). When tested separately, animals from the tg60 line also
showed poor performance in the exercise test.
Figure 5. The Running endurance exercise performance.
Performance in the exercise tests as indicated by A. running distance,
B. vertical distance, C. vertical work performance. Results are expressed
as mean6SD **P,0.01, Mecr transgenic mice vs. wild type control.
doi:10.1371/journal.pone.0005589.g005
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Phenotype analysis of the mice overexpressing Mecr revealed the
existence of a novel link between expression of FAS II genes,
mitochondria and mechanical function in myocardium tissue.
Northern blot analysis of samples from various mammalian tissues
has shown that heart muscle is among the tissues showing high
mRNA levels for genes of FAS II [3,4,8,11]. The overexpression of
Mecr in mice resulted in development of myocardial dysfunction as
demonstrated by several lines of evidence. The Mecr transgenic
animals have impaired mechanical heart function in vivo as
documented by (i) echocardiography and (ii) decreased physical
performance in exercise endurance tests. (iii) In perfusion
experiments, the isolated hearts from transgenic mice did not
increase work output linearly upon increasing the beating rate by
electric pacing whereas this correlation was linear with hearts from
wild type mice. (iv) Both light and electron microscopy showed
disorganization in cardiac myofibrils. Transmission electron
microscopy further revealed a high density of cristae and focal
clumping of mitochondria in myocardium.
To rule out the possibility that the observed phenotypes are due
to construct-dependent interruption of endogenous genes involved
in heart function, we analyzed two independent transgenic mouse
lines using different approaches. Southern blotting proved that the
transgenes were incorporated in a line-specific manner and that
different numbers of copies were inserted into distinct but not
multiple sites in the genome (Figure 1C). It is unlikely that
construct integration into different loci of mouse genome per se
would confer the same phenotype. Therefore, the findings favor
the view that the phenotype of the transgenic mice resulted from
the overexpression of the construct rather than from interruption
of an endogenous gene.
Echocardiographic monitoring of cardiac function in vivo
showed that ejection fraction and fractional shortening were
reduced in Mecr transgenic mice. Additionally, these mice showed
a tendency to have increased left ventricular mass and dilatation of
the left ventricle, suggesting a dilatative rather than a hypertrophic
process behind the impaired function. This was corroborated in
isolated perfused hearts, which showed decreased work output in
the Mecr transgenic hearts. When the pacing was increased to
10 Hz, the wild type hearts responded, but many of the Mecr
transgenic hearts failed to follow the pacing. Noteworthily, the
levels of mRNAs of heart failure mark genes and their relevant
transcription factors did not show significant changes in Mecr
transgenic hearts compared to wild type controls.
The Mecr transgenic mice showed diminished performance in
the endurance test, resembling one of the hallmark symptom of
patients with dilatative cardiomyopathy [25]. The running
distance of the Mecr transgenic mice before fatigue is about half
of that of wild type controls. It is worth noting that transmission
electron microscopy of skeletal muscle did not reveal clumping of
mitochondria nor was myofibrillar disorganization detected.
Haematoxylin-eosin staining and transmission electron micro-
graphs showed focal distortion of myofibers in the Mecr transgenic
mouse hearts, accompanied by aggregation and an unusual
ultrastructure of the mitochondria. The increased density of
cristae that was observed in the heart mitochondria of Mecr
transgenic mice resembles a feature of mitochondria from skeletal
muscles found in Luft disease [26]. Significantly, the average size
of mitochondria from Mecr transgenic hearts is greater than that of
controls (Figure 2B, b6). The morphological changes of Mecr
transgenic mitochondria may be partially responsible for altered
oxygen consumption and function of the transgenic hearts upon
challenging as vocalized by heart perfusion experiments. Thus, the
mitochondrial phenotype observed previously in yeast upon
overexpression of Etr1 [12] , can be reproduced in mice, at least
in part, demonstrating conserved regulatory mechanisms. The
mitochondrial swelling in yeast is not due to the loading of yeast
mitochondria with Etr1p, but requires an unidentified signal from
the mitochondria to the nucleus [12,27].
Inbacteriaandintheplastidsofplants,FASIIservesasthe major
route for generation of cellular fatty acids [9], whereas in yeast and
mammals, the end-products of the mitochondrial FAS system
constituteonlyasmallfractionofcellularfattyacidsand theirnature
has not yet been identified conclusively. The proposed products
include anlong-chainacyl groupsforremodelingofcardiolipinsand
octanoyl group for lipoic acid synthesis [13,28]. Cardiolipins are
acidic phospholipids found mainly in the mitochondrial inner
membrane in mammals [29]. Even though lipoic acid is regarded as
a fat soluble vitamin, mammalian mitochondria also contain lipoic
acid synthase [30]. In cells, lipoic acid is covalently attached to the
E2 subunits of mitochondrial a-ketoacid dehydrogenase complexes
[31]. Recently a mouse model carrying disruption of Lias,g e n e
encoding lipoic acid synthase, has been described [31]. Interesting-
ly, this disruption resulted in embryonic lethality due to failure in
development of haematopoietic and cardiovascular system.
There may be several reasons for our failure to detect
overexpression of Etr1/Mecr at the protein level using either whole
heart preparations or isolated mitochondria. The amount of
endogenous Etr1/Mecr in mitochondria is very low [4], and the
fact that we had the antibody to human but not to mouse protein
might make its detection more difficult. Another similar example is
Aurora A transgenic mice, when Aurora A protein is overexpressed,
it is ubiquitinated by the cells, which targets it toward the
ubiquitin-linked protein degradation system. Thus, overexpression
can only be detected at the mRNA level [32].
The rather similar phenotype of tg60 and tg62 mice lines raises
a possibility that Mecr expression is controlled post-transcription-
ally either at translational or post-translational levels. These
options are currently under investigation in our laboratory.
Interestingly, it has been reported that mice transgenic for the
MT-1-driven tpr-met oncogene develop a clear tumor phenotype,
while the overexpression is detectable neither at the mRNA level
nor at the protein level in any tissues except tumors [33].
Our transgenic mice resemble to some extent moderately
overexpressing caspase-8 transgenic mice [34], whose survival rates
do not significantly differ from wild type mice and which developed a
dilated heart and decreased systolic function. We are on the way to
generate Mecr cardiac specific expression transgenic mice as well as
Mecr knockout mice. When these transgenic lines are available, we are
going to addresses several issues: (i) how the expression levels of Mecr
are regulated in vivo;( ii) the molecular and physiological mechanisms
of the cardiac phenotype of the Mecr transgenic mice; (iii) whether the
poor exercise performance of the Mecr transgenic mice is solely
because of the overexpression of Mecr in cardiac myocytes.
Based upon the data we obtained from various independent
experiments, we conclude that the Mecr transgenic mice suffer from
a heart dysfunction which is obviously linked to an impairment in
mitochondrial function. This is in line with reports suggesting that
there exists a correlation between mitochondrial dysfunction and
contractile dysfunction of heart [35]. We expect that the Etr1/Mecr
transgenic mice could provide a research model to study the
physiological function of the mitochondrial FAS II in mammals.
Materials and Methods
Two lines of Mecr transgenic mice were generated and their
expressions are under control of MT-I promoter. PCR and
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RCR and Semiquantitative real time PCR were applied to check
the expression level of Mecr and other mark genes. Male animals at
the age of 1–1.5 years were used if not otherwise stated. Notably,
similar phenotypic changes were also observed in younger mice
(e.g., at the age of 6–7 months). All experiments were performed in
accordance with regulations formulated by the Animal Care and
Use Committee of Oulu University.
Southern blot
Mouse genomic DNA was digested by BamHI. There is a single
cutting site within the overexpression construct at 4.2 kb/6 kb
(6 kb is the size of full length construct.) (Figure 1B). The probe
(1 kb) was made by digestion of the construct with PvuII; there are
two PvuII sites, at 3.3 kb and 4.3 kb, within the construct. The
intensity of the 6 kb band is proportional to the copy number of
the transgene.
Northern blot
Total RNA Northern Blot was ordered from USBiological
(Swampscott, MA). The probe (0.8 kb) was made by digestion of
the Mecr cDNA with BamHI and NotI. The experiments were
carried out according to supplied manual.
Reverse template RCR and Semiquantitative real time
PCR
The cDNAs were produced with a First Strand cDNA Synthesis
Kit (MBI Fermentas, Heidelberg, Germany) using total RNA
isolated from mouse heart and liver samples. Semiquantitative real
time PCR was performed with a 7500 Real Time PCR System
(Applied Biosystems, FosterCity, CA) using fluorogenic probe-
based TaqMan chemistry (Applied Biosystems, FosterCity, CA),
using GAPDH as an internal control for normalizing the gene
expression.
Overexpression and purification of Etr1/Mecr
cDNA of Mecr was obtained by reverse template PCR (MBI
Fermentas, Heidelberg, Germany) using oligos that can only
recognize artificial Mecr sequence from tg62 line and cloned into
pET3a and pET23a vectors. The overpression, purification of His-
tagged protein and enzymatic assays were carried out using the
protocol as described in [36].
Histological analysis
The heart tissue samples were fixed in phosphate buffered 4%
paraformaldehyde and embedded in paraffin, and 4 mm sections
were stained with haematoxylin-eosin according to standard
protocols. TUNEL staining was done according to the instructions
provided with the in situ cell death detection kit (Roche
Diagnostics, Mannheim, Germany). The sections were examined
using an Olympus BX50 light microscope and analyzed using
software supplied (Soft Imaging Systems, Munster, Germany).
For transmission electron microscopy (TEM), tissue samples
from mouse heart were fixed in 1% glutaraldehyde and 4%
formaldehyde in 0.1 M phosphate buffer, pH 7.2, and then
dehydrated in acetone and embedded in Embed 812 (Electron
Microscopy Sciences, Fort Washington, PA). Thin sections of
80 nm were cut by a Leica Ultracut UCT ultramicrotome and
examined in a Philips CM100 transmission electron microscope.
Echocardiographic analysis
The cardiac function of both male and female mice was
evaluated using echocardiography. The dimensions of cardiac
chambers and left ventricular function were assessed using
transthoracic echocardiography with an Acuson Ultrasound
System (Sequoia 512) and a 15-MHz linear transducer (15L8).
Ketamine (50 mg/kg IP) and xylazine (10 mg/kg IP) were used
for anesthesia. A short-axis view of the left ventricle at the level of
the papillary muscles was obtained by using 2D imaging for the M-
mode recording. Left ventricular end-systolic (LVESD) and end-
diastolic (LVEDD) dimensions as well as thickness of interventric-
ular septum (IVS) and posterior wall (PW) were measured from the
M-mode tracings. LV fractional shortening (LVFS) and ejection
fraction (EF) were estimated from the M-mode LV dimensions by
applying the following formulas: LVFS (%)=[(LVEDD2L-
VESD)/LVEDD]6100 and EF (%)=[(LVEDD
32LVESD
3)/
LVEDD
3]6100.
Heart perfusion
The mice were sacrificed by decapitation after cervical
dislocation. The aorta was immediately cannulated and perfusion
commenced in situ with ice-cold perfusion medium. The heart was
then dissected out and connected to the perfusion apparatus. The
perfusion fluid was Krebs-Henseleit perfusion medium containing
118.5 mmol/L NaCl, 4.7 mmol/L KCl, 2.5 mmol/L CaCl2,
0.25 mmol/L Ca-EDTA, 1.2 mmol/L MgSO4, 1.2 mM
KH2PO4, 25 mmol/L NaHCO3, 10 mmol/L glucose. The hearts
were then perfused in a modified Langendorff apparatus with a
pressure of 100 cm H2O (9.81 kPa) and with the medium
maintained by a thermostat at 37uC and with an O2:CO2 ratio
of 19:1. The heart rate, left ventricular systolic pressure, coronary
flow, and oxygen consumption were measured. There was a
stabilization period of at least 30-minutes before electrical pacing
with an epicardial Ag/AgCl electrode was begun at a voltage 50%
above the threshold. All experiments ended with freeze-clamping
of the heart.
The heart was enclosed in a thermostated, light-tight chamber
equipped with fiber optics for epicardial readout of reflectance
spectrum changes (605 nm versus 630 nm for cytochrome c
oxidase) and fluorescence (emission above 510 nm with 465-nm
excitation for flavin) by means of a three-channel spectrophotom-
eter-fluorometer and the data collected via DAQ-card (National
Instruments, Austin, TX) and stored on a PC at 2-s intervals. Left
ventricular pressure was monitored through the ventricular wall by
inserting a saline-filled Teflon cannula connected to a Statham
P231D pressure transducer linked to a Statham SP1400 pressure
monitor. The pressure wave signal was fed to a Lab-PC+ data
acquisition card (National Instruments, Austin, TX) and heart
function parameters (heart rate, peak systolic pressure, diastolic
pressure and peak pressure development) were calculated on-line
with custom designed software and stored on a computer at 4-s
intervals. Coronary flow was measured during the experiments by
using a drop counter with an analog frequency output. Oxygen
consumption was calculated from the arteriovenous concentration
difference multiplied by coronary flow.
Metabolite assays
The heart was quick-frozen with aluminum clamps precooled in
liquid nitrogen, and stored in liquid N2 until processed further.
The frozen heart tissue was immersed in 8% (wt/vol) HClO4 in
40% (vol/vol) ethanol precooled to 220uC, and homogenized
immediately with an Ultra-Turrax homogenizer (Ika Werk,
Midland, ON, Canada). After centrifugation the supernatant
was neutralized with 3.75 mol/L K2CO3 containing 5 mol/L
triethanolamine hydrochloride [37].
Creatine phosphate (CrP), creatine (Cr) and inorganic phos-
phate levels were measured in the supernatant by enzymatic assays
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measured in an Aminco DW-2 dual-wavelength spectrophotom-
eter using an e340 minus e385 value of 5.33 L/mmol per centimeter
[38,39].
Measurements of mitochondrial O2 consumption
Rates of oxygen consumption in the presence of various
substrates were measured polarographically with the Rank
Brothers oxygen electrode (Bottisham, Cambridge, UK). The
incubation medium contained 130 mM KCl, 10 mM HEPES,
5 mM potassium phosphate, 0.1 mM EGTA, 1 mg/ml bovine
serum albumin (essentially fatty acid free) and 2 mM MgCl2,
pH 7.2. The incubations contained 0.5–1.2 mg/ml of mitochon-
drial protein in a final volume of 0.7 ml at 30uC, and substrates as
given.
Exercise performance test
The animals were subjected to exercise performance tests. The
previous protocol [40] was revised slightly with respect to speed
and inclination. Two days before the exercise performance test, all
mice were familiarized with running on a motorized running belt
with rotating flexible plastic strips at the rear of the treadmill to
prod the mice to run. 10 min exercise with a treadmill inclination
of 9u was used for the familiarization run. Treadmill speed was
9 m/min on the first day and 11 m/min on the second day.
Before the final test, mice were placed on the belts and allowed to
adapt to the surroundings for 5 min before running. The treadmill
was started at a speed of 9 m/min with a 0u slope for 9 min. Then
the speed and inclination were raised to 11 m/min and 6u,
respectively. Speed was increased by 1–3 m/min every 3 min to a
maximum of 28 m/min, and the inclination gradually increased
by 3u every 9 min to a maximum of 12u. Exercise was stopped
when mice were unable to maintain running despite repeated
contact with the rotating plastic strips. Each mouse was then
immediately returned to its home cage from the treadmill.
Exercise performance was assessed from the performance tests
based on the following three parameters: the duration of the run
(in minutes), the distance run (in meters), and vertical work
performance (in kgNm). Vertical work performance was calculated
as the product of body weight (kg) and vertical distance (meters),
where vertical distance equals distance run 6sina, where a is the
slope of the treadmill from 0u to 12u.
Statistical Analysis
Values are expressed as mean6standard deviation (SD) and
analyzed by the Student’s t test for detecting significant differences.
The haemodynamic variables were analyzed with 2-way repeated-
measures ANOVA. Echocardiographic measurements were ana-
lyzed using normalized values with 1-way ANOVA followed by
the Student-Newman-Keul post hoc test. A value of P,0.05 was
considered statistically significant.
Supporting Information
Table S1 The rates of state 3 and 4 respiration of liver and heart
mitochondria with various substrates. The liver and heart
mitochondria were isolated as described [1] after 12 h fast. The
incubations were carried out with 0.5–1.2 mg/ml of mitochon-
drial protein at 30uC in the appropriate medium (Materials and
Methods) and 2 mM glutamate, 2 mM malate, 2 mM pyruvate,
or 2 mM succinate. ADP was used at 1 mM concentration. The
rate of oxygen consumption (nmol O2/min per mg protein) was
monitored with Clark type oxgen electrode. The results are
expressed as mean6standard deviation. The statistical significance
was estimated using the Student’s t test and the P-values are given.
Found at: doi:10.1371/journal.pone.0005589.s001 (0.02 MB
DOC)
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